LYRVX | VIHAX | LYRVX / VIHAX | |
Total Expense Ratio | N/A | N/A | - |
Annual Report Gross Expense Ratio | N/A | N/A | - |
Fund Existence | 2 years | 9 years | - |
Gain YTD | -0.507 | 5.296 | -10% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 1000 | 3000 | 33% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 12.4M | 8.4B | 0% |
Annual Yield % from dividends | 1.24 | 4.87 | 25% |
Returns for 1 year | 2.76 | 8.15 | 34% |
Returns for 3 years | N/A | 9.76 | - |
Returns for 5 years | N/A | 14.60 | - |
Returns for 10 years | N/A | N/A | - |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
VLCGX | 21.71 | -0.07 | -0.32% |
VALIC Company I Large Capital Growth | |||
FZEMX | 39.47 | -0.14 | -0.35% |
Fidelity Advisor Emerging Markets Z | |||
LBDRX | 20.34 | -0.11 | -0.54% |
BrandywineGLOBAL Div US Large Value R | |||
HCMIX | 36.08 | -0.26 | -0.72% |
HCM Tactical Growth I | |||
RYBHX | 51.65 | -0.60 | -1.15% |
Rydex S&P MidCap 400 Pure Growth H |